Biological influences on obesity

Pediatric Clinics of North America

Volumn 48, Issue 4, 2001, Pages 879-891

  Schonfeld Warden, Nancy A ^a   Warden, Craig H ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHILD; CHILDHOOD DISEASE; DISEASE CLASSIFICATION; ENVIRONMENTAL FACTOR; GENE EXPRESSION; GENE MUTATION; HUMAN; OBESITY; PHARMACOGENETICS; REVIEW;

EID: 0034900002     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-3955(05)70346-1     Document Type: Article

References (31)

1. Genetic susceptibility to type 1 diabetes: Clinical and molecular heterogeneity of IDDM1 and IDDM12 in a German population
2. Genetics of body-weight regulation
3. Molecular pharmacology of Agouti protein in vitro and in vivo
4. Molecular characterization of the mouse agouti locus
5. A unique metabolic syndrome causes obesity in the melanocorfin-3 receptor-deficient mouse
6. Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy
7. The human obesity gene map: The 1999 update
8. Monogenic disorders of obesity and body fat distribution
9. Monogenic disorders of obesity and body fat distribution
10. Making and reading microarrays
11. Effects of recombinant leptin therapy in a child with congenital leptin deficiency
12. Recent advances in the genetics of severe childhood obesity
13. Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency
14. Leptin and the regulation of body weight in mammals
15. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring
16. Maturity-onset diabetes of the young: Clinical heterogeneity explained by genetic heterogeneity
17. Familial partial lipodystrophy: A monogenic form of the insulin resistance syndrome
18. Normal variation in leptin levels in associated with polymorphisms in the proopiomelanocortin gene, POMC
19. Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene
20. Mutations in MKKS cause obesity, retinal dystrophy and renal malformations associated with Bardet-Biedl syndrome
21. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans
22. Implications of proopiomelanocortin (POMC) mutations in humans: The POMC deficiency syndrome
23. Melanocortin 3 receptor (MC3R) gene variants in extremely obese women
24. Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor
25. Congenital leptin deficiency is associated with severe early-onset obesity in humans
26. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein
27. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers
28. Human genomics and obesity: Finding appropriate drug targets
29. Quantitative monitoring of gene expression patterns with a complementary DNA microarray
30. Mutations in MKKS cause Bardet-Biedl syndrome
31. Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity